Pieris Pharmaceuticals Inc (PIRS) Sof marja

Pieris Pharmaceuticals Inc (PIRS) grafik logotipi

Yuqori doimiy sinov xarajatlari joriy savdo marjasi darajasida aks etgan xavflarni yuzaga keltirmoqda; 0.00 ko'rsatkichning joriy qiymatini ifodalaydi. Stephen Yarrow'ning portfelni optimallashtirish uchun yangi hamkorlar qidiruvi barqarorlikni tiklaydi. Dori ishlab chiqarishni ixtisoslashtirilgan kontrakt tashkilotlariga autsorsing qilish Pieris Pharmaceuticals (PIRS) kompaniyasining R&D infratuzilmasidagi kapital yuklarini kamaytirib, qo'shimcha tayanchni ta'minlaydi.

Pieris Pharmaceuticals (PIRS) - Kompaniya sotuv marjasi 04.07.2022dan 19.11.2026gacha

Pieris Pharma (PIRS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning umumiy tahlili:Pieris Pharmaceuticals, Inc. - PIRS
Pieris tayyor mahsulotlari

Sotuv marjalari daromadning har bir dollari ichidagi sof foyda ulushini belgilab, biznesning umumiy samaradorligini aks ettiradi. Investor mahalliy cho'qqilarda impulsiv xaridlarning oldini olgan holda, haqiqiy daromadlilikni baholash uchun kompaniyaning sof marja koeffitsiyentidan foydalanadi. Ushbu ko'rsatkich aktivning barcha xarajatlardan keyin foyda keltirish qobiliyatini ochib beradi. Pieris Pharmaceuticals (PIRS) uchun bu anti-kallikreinlar ishlab chiqilayotgan davrda moliyaviy barqarorlikni tasdiqlaydi. Brendning onkologiya sohasidagi ilmiy nufuzi bunday hisob-kitoblarning hayotiy ekanligini ta'minlaydi.

Pieris Pharmaceuticals kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Sof marja|Sotuvning sof rentabelligi MNKD|Sof marja Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi SPRY|TBPH - Sof marja|Aquestive Pharma - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi scpharmaceuticals.com SCPH|Tectonic - Sotuvning sof marjinal rentabelligi|TNXP - Sotuvning sof marjinal rentabelligi|SXTC: Sotuvning sof marjinal rentabelligi|Eupraxia Pharma - Sof foyda normasi|BHST (bioharvest.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi EXOZ (invizyne.com)|Sotuvning sof marjinal rentabelligi ORMP|Kompaniya sotuv marjasi Entera Bio|Sotuvning sof marjinal rentabelligi HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Sof marja|Cumberland Corp - Sotuvning sof marjinal rentabelligi|QNTM - Sotuvning sof marjinal rentabelligi|FibroGen, Inc. (FGEN) - Sof marja|TELO: Kompaniyaning sof rentabelligi|RANI (Rani Therapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sof marja synergychc.com SNYR|Sof marja Rallybio Corp. (RLYB)|LEXX - Sof marja|Sotuvning sof marjinal rentabelligi PULM (pulmatrix.com)|Kompaniyaning sof rentabelligi PTHL (Pheton)|APM - Sof marja|Kompaniya sotuv marjasi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Sof marja|TNF Pharma (TNFA) - Sotuvning sof marjinal rentabelligi|YCBD (cbdmd.com) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi PainReform (PRFX)|Sof marja Altamira Therapeutics (CYTO)|Kompaniya sotuv marjasi Lipella Pharma|Optinose - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma